Table 1 General clinical characteristic of mammary gland tumors with female dogs.
From: Combined detection of CA15-3, CEA, and SF in serum and tissue of canine mammary gland tumor patients
Clinical characteristics | Number | Frequency (%) |
|---|---|---|
Control group | 40 | |
Ages | ||
≥ 10 | 24 | 60 |
< 10 | 16 | 40 |
Benign tumor group | 82 | |
Ages | ||
≥ 10 | 46 | 56.1 |
< 10 | 28 | 43.9 |
Tumor size (cm) | ||
T1 (< 3) | 32 | 39 |
T2 (3 ≤ T ≤ 5) | 27 | 32.9 |
T3 (> 5) | 23 | 28.1 |
Histological type | ||
Intraductal papilloma | 26 | 31.7 |
Adenopathy | 19 | 23.2 |
Fibrosadenoma | 15 | 18.3 |
Ductal and lobular hyperplasia | 8 | 9.7 |
Other tumors | 14 | 17.1 |
Malignant tumor group | 56 | |
Ages | ||
≥ 10 | 23 | 41.2 |
< 10 | 33 | 58.8 |
Tumor size (cm) | ||
T1 (< 3) | 12 | 21.4 |
T2 (3 ≤ T ≤ 5) | 28 | 50 |
T3 (> 5) | 16 | 28.6 |
Histological type | ||
Infiltrating ductal carcinoma | 30 | 53.6 |
Ductal carcinoma in situ | 5 | 8.9 |
Invasive micropapillary carcinoma | 7 | 12.5 |
Intracystic papillary carcinoma | 3 | 5.4 |
Intraductal papillary carcinoma | 6 | 10.7 |
Others carcinoma | 5 | 8.9 |
Histologic grade | ||
I | 21 | 37.5 |
II | 25 | 44.6 |
III | 10 | 17.9 |
